Page 483 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 483

Fluid, Electrolyte, and Acid-Base Disturbances in Liver Disease  471



                                       Portal hypertension  Portosystemic shunting
                          iNOS   Nitric oxide                       Acquired PSS
                                                 Vasodilated        large varices      Hypoalbuminemia
                          Transmural bacterial
                              passage         splanchnic circulation                          3rd space
                                               Peripheral arterial  Arteriovenous shunts  Synthesis
                             Endotoxins         vasodilatation  (splanchnic and pulmonary)    distribution  Loss into
                                                                                                         intestine:
                          Vasodilatory effects:                                                Peripheral  PLE
                         peptides: glucagon, VIP,                                    Catabolism vasodilatation:
                        bile salts, prostaglandins,               Gravitational pooling         Dilution
                          local autonomic tone  “Vascular underfilling”  (splanchnic vasculature)
                   Signals sodium and       Non-osmotic baroreceptors
                   water conservation                                                    Free cortisol
                                          Sympathetic nervous system  Vasopressin  Bile salts  ACTH
                         Renal
                      angiotensin II            Renin-angiotensin-aldosterone             Inhibition
                                                                                      11 -hydroxysteroid
                                                                                        dehydrogenase
                                                               Cardiac output
                   Efferent  Vasoconstriction  Vasodilatory                                  “Apparent”
                  arteriole                 renal prostaglandins  Hyperdynamic  Abnormal release  mineralocorticoid
                                                                             mineralocorticoid
                                                               circulatory                     excess
                     Filtration fraction                       syndrome
                                         Perfusion redistribution:
                     Filtrate absorption:  Cortex  Juxtaglomerular                  Aldosterone
                      proximal tubule               tubules                           escape
                                                                                     Renal sodium
                                             GFR              Impaired excretion
                        Peritubular                            solute-free H 2 O      retention
                   fluid and sodium resorption
                                           Adequately normalizes               Fails to normalize
                     Renal sodium and H 2 O  circulatory homeostasis  Plasma volume  circulatory homeostasis
                          retention
                 Portal hypertension/lymph formation
                                                 Normalization             Persistent activation

             Intrahepatic portal                  Na  and H 2 O              Na    and H 2 O
               hypertension                     retaining systems           retaining systems
                               Fluid exudation from
             Up to 10   increase in  splanchnic/visceral  Normal excretion:  Continued retention:  Renal


             hepatic lymph formation             Na  and H 2 O        Na  and H 2 O  vasoconstriction
                                   lymphatics
             Fluid “weeping” from                                                         Functional
               hepatic capsule                    No ascites          Ascites           renal insufficiency
                                                                                    HEPATORENAL SYNDROME
                        Figure 19-10 Diagram showing the pathophysiologic mechanisms associated with ascites formation in
                        patients with chronic hepatic insufficiency.
            underlying ascites formation. Decreased systemic vascular  hypertension, which are caused by increased hepatic sinu-
            resistance initially arises as a consequence of marked  soidal resistance resulting from hepatic fibrosis. Increased
            splanchnic arterial vasodilatation. The mechanisms  intrasinusoidal pressure combined with high splanchnic
            underlying splanchnic vasodilatation are poorly under-  capillary pressure and decreased oncotic pressure can
            stood but likely involve enhanced availability, synthesis,  cause an up to a twentyfold increase in hepatic lymph for-
            or activity of vasodilatory factors such as NO, glucagon,  mation, exceeding the drainage capacity of the thoracic
            vasoactive intestinal peptide, endotoxin, bile acids,  and hepatic lymphatics. Lymph subsequently weeps from
            prostaglandins, and increased local autonomic tone.  the surface of the liver or splanchnic vasculature into the
            Splanchnic vasodilatation promotes abnormal distribu-  peritoneal space, causing ascites. Hypoalbuminemia is
            tion of circulating blood volume away from the systemic  notably absent early in this syndrome. Formation of asci-
            circulation.Theresultingsystemichypoperfusionissensed  tes continues in response to the ongoing systemic
            by arterial baroreceptors, which signal a need for vasocon-  counter-regulatory response (e.g., RAAS-mediated renal
            striction and sodium and water retention by the kidneys  sodium retention, nonosmotic stimulation of AVP
            (e.g., activation of the RAAS and SNS, release of AVP).  release). In some patients, these compensatory responses
            These events establish a hyperdynamic state characterized  can culminate in development of HRS and acute renal
            by increased cardiac output, decreased systemic vascular  failure.
            resistance, and arterial vasodilatation affecting both the  Albumin infusions do not consistently improve circu-
            splanchnic and systemic circulation.                latory and renal function in cirrhotic patients with ascites
              Increased splanchnic capillary hydrostatic pressure  because of enhanced movement of albumin from vessels
            arises from increased splanchnic blood flow and portal  into the interstitium and severe vasodilatation of the
   478   479   480   481   482   483   484   485   486   487   488